The airway epithelium in asthma: Developmental issues that scar the airways for life?

• Published in: Pulmonary pharmacology & therapeutics 2012-12, Vol.25 (6), p.420-426
• Main Authors: Roth, Hollis M, Wadsworth, Samuel J, Kahn, Michael, Knight, Darryl A
• Format: Article
• Language: English
• Subjects: Airways; Allergens - immunology; Animals; Asthma; Asthma - immunology; Asthma - pathology; Epithelium; Humans; Hypersensitivity - immunology; Immune barrier; Inflammation - pathology; Inhalation Exposure - adverse effects; Lung; Lung disease; Medical Education; Pulmonary; Pulmonary/Respiratory; Respiratory Mucosa - pathology; Wnt/β-catenin signaling
• ISSN: 1094-5539; 1522-9629
• DOI: 10.1016/j.pupt.2012.09.004

Abstract While allergies are very common, affecting ∼40% of the population in most Western countries, only a proportion of allergic people develop asthma. This highlights the importance of tissue and cell specific mechanisms that contribute to the disease. As the interface between the inhaled environment and the internal environment of the lung, the epithelium normally possesses numerous mechanisms to maintain an effective protective barrier. However, the inability of the airway epithelium of asthmatics to effectively defend the lung against normally innocuous inhaled agents strongly suggests that asthma must involve defects in the epithelial barrier rather than being primarily an allergic disease. Evidence is accumulating that in asthma, the epithelium does not go through normal stages of development and differentiation and as a consequence, remain somewhat “immature”. This in turn leads to a chronic cycle of dysregulated damage and repair which ultimately impacts on the airways function by increasing inflammation, but also by initiating processes that ultimately lead to changes to the structure and function of the airway.